Cargando…

A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease

BACKGROUND/AIMS: The aim of this study was to evaluate the efficacy and cost efficiency of omeprazole 10 mg and rabeprazole 10 mg once daily for 24 weeks in the maintenance therapy. METHODS: This was a randomized, open-label study enrolling 279 patients with erosive esophagitis A or B (Los Angeles c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jung Ho, Park, Hyojin, Lee, Dong Ho, Sung, In Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644658/ https://www.ncbi.nlm.nih.gov/pubmed/23667753 http://dx.doi.org/10.5056/jnm.2013.19.2.219

Ejemplares similares

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis
por: Nagahara, Akihito, et al.
Publicado: (2013)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020)

The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013)

Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation
por: Hosseini, Mousalreza, et al.
Publicado: (2018)

Is Gastroesophageal Reflux Disease and Achalasia Coincident or Not?
por: Jung, Da Hyun, et al.
Publicado: (2017)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Gaviscon(® )vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
por: Pouchain, Denis, et al.
Publicado: (2012)

Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail
por: Li, Feng, et al.
Publicado: (2022)

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
por: Garcia, R.S., et al.
Publicado: (2017)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
por: Abbasinazari, Mohammad, et al.
Publicado: (2014)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
por: Sirinawasatien, Apichet, et al.
Publicado: (2019)

Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
por: Karyampudi, Arun, et al.
Publicado: (2017)

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus
por: Kee, Ping Siu, et al.
Publicado: (2022)

Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study
por: Lim, Hyun Chul, et al.
Publicado: (2013)

A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form
por: Raval, P. B., et al.
Publicado: (2008)

A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan
por: Nagahara, Akihito, et al.
Publicado: (2014)

A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life
por: Mizuki, Akira, et al.
Publicado: (2016)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Regional Food Causing Symptoms of Gastroesophageal Reflux Disease
por: Park, Jung Ho
Publicado: (2017)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study
por: Alecci, Umberto, et al.
Publicado: (2016)

Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux
por: Shin, Myung-Hee, et al.
Publicado: (2012)

Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review
por: Monzani, Alice, et al.
Publicado: (2010)

Anti-reflux Surgery Versus Proton Pump Inhibitors for Severe Gastroesophageal Reflux Disease: A Cost-Effectiveness Study in Korea
por: Park, Susan, et al.
Publicado: (2020)

Cost-effective Management of Severe Gastroesophageal Reflux Disease: Toward an Improved Understanding of Anti-reflux Surgery
por: Park, Chan Hyuk
Publicado: (2020)

Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole
por: Liu, Wenjun, et al.
Publicado: (2022)

Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
por: Jo, So Young, et al.
Publicado: (2013)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study
por: Kim, Young Min, et al.
Publicado: (2022)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
por: Frye, Jeanetta W, et al.
Publicado: (2015)

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease
por: Gong, Eun Jeong, et al.
Publicado: (2019)

A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
por: Park, Su Hyun, et al.
Publicado: (2023)

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_shsljp13t1ttbg87l1rurp9j5o